Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE, Mass., Jan.

Biogen’s applications for the higher dose regimen of SMA drug Spinraza are now under review in the US and Europe.

Spinraza remains a big product for Biogen, but has seen its sales go into reverse as competition in SMA treatment has emerged ...

Biogen Inc. announced that the FDA has accepted and the EMA has validated its supplemental New Drug Application for a higher dose regimen of nusinersen, intended for treating spinal muscular ...

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE ...

The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months, compared to the approved nusinersen ...

The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months, compared to the approved nusiner ...

SMA treatment in India currently faces significant hurdles. Among the three globally available treatments—gene therapy Zolgensma, Spinraza (Nusinersen), and Evrysdi (Risdiplam)—only Evrysdi is ...

Welcome to Sportstar’s live coverage of the second Vijay Hazare Trophy semifinal between Vidarbha and Maharashtra. Stay tuned for live scores and updates from the game.

PAK vs WI: Pakistan and West Indies are set to clash in their last Test series of the World Test Championship 2025 cycle in Multan starting on January 17. Both teams enter this two-match series ...

The timing of this series does not exactly help raise its profile. It comes after the top two World Test Championship (WTC) berths have been decided at the tail-end of the cycle. West Indies are ...